Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Gamida Cell's Enterprise Value is $38.47 Mil.
Gamida Cell's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-55.41 Mil. Therefore, Gamida Cell's EV-to-EBIT ratio for today is -0.69.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Gamida Cell's Enterprise Value is $38.47 Mil.
Gamida Cell's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-53.39 Mil. Therefore, Gamida Cell's EV-to-EBITDA ratio for today is -0.72.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Gamida Cell's Enterprise Value is $38.47 Mil.
Gamida Cell's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $1.78 Mil. Therefore, Gamida Cell's EV-to-Revenue ratio for today is 21.56.
Gamida Cell Enterprise Value Historical Data
The historical data trend for Gamida Cell's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Gamida Cell's Enterprise Value
For the Biotechnology subindustry, Gamida Cell's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gamida Cell's Enterprise Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gamida Cell's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Gamida Cell's Enterprise Value falls into.
Gamida Cell Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Gamida Cell's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gamida Cell (OTCPK:GMDAQ) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Gamida Cell's current Enterprise Value is $38.47 Mil.
Gamida Cell's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-55.41 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Gamida Cell's current Enterprise Value is $38.47 Mil.
Gamida Cell's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-53.39 Mil.
Gamida Cell's current Enterprise Value is $38.47 Mil.
Gamida Cell's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gamida Cell Enterprise Value Related Terms
Thank you for viewing the detailed overview of Gamida Cell's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Gamida Cell Ltd is a clinical-stage biopharmaceutical company that is pioneering a diverse immunotherapy pipeline of potentially curative cell therapy candidates for patients with solid tumors and blood cancers and other serious blood diseases. The company applies a proprietary expansion platform leveraging the properties of nicotinamide, or NAM, to allogeneic cell sources including umbilical cord blood-derived cells and natural killer, or NK, cells to create cell therapy candidates with the potential to redefine standards of care. Its primary product candidate is Omidubicel, an advanced cell therapy candidate for allogeneic hematopoietic stem cell transplant and GDA-201 is the company's lead investigational NK cell-based cancer immunotherapy product candidate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GMDAQ has been successfully added to your 